跳至主要内容
临床试验/NCT07538141
NCT07538141招募中不适用

The Hyalex First-in-Human Study - A Prospective, Single-Arm, Feasibility Study of the HYALEX SLALOM MTP Hemiarthroplasty Implant

Hyalex Orthopaedics, Inc.1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
20
试验地点
1
主要终点
Freedom from implant rejection, infection

研究概览

简要总结

The HYALEX SLALOM MTP Hemiarthroplasty System consists of a synthetic implant designed to replace the distal metatarsal surface of the great toe for treatment of arthritis . The system is composed of the HYALEX MTP Implant and instrumentation. The implant consists of the HYALEX Cartilage material bonded to a titanium backing.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 21-75 years;
  • Body Mass Index (BMI) ≤ 38;
  • Degenerative or post-traumatic arthritis of the first metatarsal joint with ICRS grade 2, 3, or 4;
  • Pre-operative VAS pain score of >40;
  • Presence of good bone stock, without need for bone graft

排除标准

  • Known allergy to polyurethanes, bone cement, acrylic, or titanium;
  • Due to anatomy and/or lesion location, inability to position the implant flush or slightly proud relative to the articular surface precluding proper device placement;
  • Lack of 2mm of vital bone on all sides of implant site;
  • Cartilage lesions on the phalanx of ICRS Grade 3 - 4 opposite the lesion intended for treatment;
  • Additional ipsilateral lower limb (hip, knee, ankle, or foot) pathology that requires active treatment (e.g., surgery, brace);
  • Bilateral degenerative or post-traumatic arthritis of the MTP joints that would require simultaneous treatment of both MTP joints;
  • Previous cheilectomy resulting in inadequate bone stock;
  • Diagnosis of gout;
  • Hallux varus to any degree or hallux valgus >20;
  • Hyper mobility at proximal metatarsal joint;
  • Interphalangeal angle >15

研究组 & 干预措施

Implantation of HYALEX SLALOM MTP Hemiarthroplasty Implant

Experimental

干预措施: MTP Hemiarthroplasty (Device)

结局指标

主要结局

Freedom from implant rejection, infection

时间窗: Through 12 months

Assess the safety and performance of the HYALEX SLALOM MTP Hemiarthroplasty Implant

Improvement in VAS pain

时间窗: 12 months

VAS pain improvement over time

次要结局

未报告次要终点

研究者

发起方
Hyalex Orthopaedics, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验